Following are the questions posed and answers given by Rpharmy's Customer Experience Specialist Sherlene Christen on the April 6th USP <800> Lunch + Learn.
Q: What is the most extensive list of hazardous drugs you have seen?
A: The largest one we have seen in a client whom we have helped implement Rhazdrugs is 365 drugs. That client was very active in assessing every new drug that came in the door. The smallest was in the 50-60 range and those are usually clients that don’t have an infusion center. They don’t handle a lot of IV medications. Most of what they have are simple sub-q injections or oral solids and liquids.
Q: If I create one assessment of risk for a group of drugs, will that meet the standard for that group of drugs?
A: The answer is NO. If you choose to create an AOR,it must show that each drug was evaluated individually, including different dosage forms for the same drug.
Q: Does USP <800> stand alone?
A: However, because USP <797>, USP <795> and USP <800> now reference each other, they are now a package deal.
Q: What states are inspecting?
A: We know Ohio and Washington State and Oregon are. Oregon’s State Board of Pharmacy has been pretty intense for several years.
